M Abigail Simmons1, Martina Brueckner. 1. aDepartment of Pediatrics (Cardiology) bDepartment of Genetics, Yale University School of Medicine, Connecticut, USA.
Abstract
PURPOSE OF REVIEW: This review has two purposes: to provide an updated review of the genetic causes of congenital heart disease (CHD) and the clinical implications of these genetic mutations, and to provide a clinical algorithm for clinicians considering a genetics evaluation of a CHD patient. RECENT FINDINGS: A large portion of congenital heart disease is thought to have a significant genetic contribution, and at this time a genetic cause can be identified in approximately 35% of patients. Through the advances made possible by next generation sequencing, many of the comorbidities that are frequently seen in patients with genetic congenital heart disease patients can be attributed to the genetic mutation that caused the congenital heart disease. These comorbidities are both cardiac and noncardiac and include: neurodevelopmental disability, pulmonary disease, heart failure, renal dysfunction, arrhythmia and an increased risk of malignancy. Identification of the genetic cause of congenital heart disease helps reduce patient morbidity and mortality by improving preventive and early intervention therapies to address these comorbidities. SUMMARY: Through an understanding of the clinical implications of the genetic underpinning of congenital heart disease, clinicians can provide care tailored to an individual patient and continue to improve the outcomes of congenital heart disease patients.
PURPOSE OF REVIEW: This review has two purposes: to provide an updated review of the genetic causes of congenital heart disease (CHD) and the clinical implications of these genetic mutations, and to provide a clinical algorithm for clinicians considering a genetics evaluation of a CHD patient. RECENT FINDINGS: A large portion of congenital heart disease is thought to have a significant genetic contribution, and at this time a genetic cause can be identified in approximately 35% of patients. Through the advances made possible by next generation sequencing, many of the comorbidities that are frequently seen in patients with genetic congenital heart diseasepatients can be attributed to the genetic mutation that caused the congenital heart disease. These comorbidities are both cardiac and noncardiac and include: neurodevelopmental disability, pulmonary disease, heart failure, renal dysfunction, arrhythmia and an increased risk of malignancy. Identification of the genetic cause of congenital heart disease helps reduce patient morbidity and mortality by improving preventive and early intervention therapies to address these comorbidities. SUMMARY: Through an understanding of the clinical implications of the genetic underpinning of congenital heart disease, clinicians can provide care tailored to an individual patient and continue to improve the outcomes of congenital heart diseasepatients.
Authors: Daphne T Hsu; Victor Zak; Lynn Mahony; Lynn A Sleeper; Andrew M Atz; Jami C Levine; Piers C Barker; Chitra Ravishankar; Brian W McCrindle; Richard V Williams; Karen Altmann; Nancy S Ghanayem; Renee Margossian; Wendy K Chung; William L Border; Gail D Pearson; Mario P Stylianou; Seema Mital Journal: Circulation Date: 2010-07-12 Impact factor: 29.690
Authors: Stephen J Pont; James M Robbins; T M Bird; James B Gibson; Mario A Cleves; John M Tilford; Mary E Aitken Journal: Am J Med Genet A Date: 2006-08-15 Impact factor: 2.802
Authors: Michael R Knowles; Leigh Anne Daniels; Stephanie D Davis; Maimoona A Zariwala; Margaret W Leigh Journal: Am J Respir Crit Care Med Date: 2013-10-15 Impact factor: 21.405
Authors: Francesco Vetrini; Lisa C A D'Alessandro; Zeynep C Akdemir; Alicia Braxton; Mahshid S Azamian; Mohammad K Eldomery; Kathryn Miller; Chelsea Kois; Virginia Sack; Natasha Shur; Asha Rijhsinghani; Jignesh Chandarana; Yan Ding; Judy Holtzman; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Christine M Eng; Neil A Hanchard; Tamar Harel; Jill A Rosenfeld; John W Belmont; James R Lupski; Yaping Yang Journal: Am J Hum Genet Date: 2016-09-08 Impact factor: 11.025
Authors: Catherine Limperopoulos; Annette Majnemer; Michael I Shevell; Charles Rohlicek; Bernard Rosenblatt; Christo Tchervenkov; H Z Darwish Journal: J Pediatr Date: 2002-07 Impact factor: 4.406
Authors: Nadine Norton; Peggy D Robertson; Mark J Rieder; Stephan Züchner; Evadnie Rampersaud; Eden Martin; Duanxiang Li; Deborah A Nickerson; Ray E Hershberger Journal: Circ Cardiovasc Genet Date: 2012-02-15
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Dimuthu Alankarage; Justin O Szot; Nick Pachter; Anne Slavotinek; Licia Selleri; Joseph T Shieh; David Winlaw; Eleni Giannoulatou; Gavin Chapman; Sally L Dunwoodie Journal: Hum Mol Genet Date: 2020-05-08 Impact factor: 6.150
Authors: Maiara A Floriani; Andressa B Glaeser; Luiza E Dorfman; Grasiela Agnes; Rafael F M Rosa; Paulo R G Zen Journal: J Pediatr Genet Date: 2020-07-29
Authors: Anna Wójtowicz; Anna Madetko-Talowska; Wojciech Wójtowicz; Katarzyna Szewczyk; Hubert Huras; Mirosław Bik-Multanowski Journal: Int J Environ Res Public Health Date: 2022-08-14 Impact factor: 4.614